Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.
about
Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic ImplicationsFuture directions for monitoring treatment response in colorectal cancerRectal cancer: An evidence-based update for primary care providers'Liver-first' approach for metastatic colorectal cancer.Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancerOutcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06).Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.Does Preoperative Radio(chemo)therapy Increase Anastomotic Leakage in Rectal Cancer Surgery? A Meta-Analysis of Randomized Controlled TrialsA multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design.Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiationLong-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategiesClinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal CancerClinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer.Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer.The best timing for administering systemic chemotherapy in patients with locally advanced rectal cancerXRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.Routine defunctioning stoma after chemoradiation and total mesorectal excision: a single-surgeon experience.Is It Possible to Shorten the Duration of Adjuvant Chemotherapy for Locally Advanced Rectal Cancer?Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation.Tumor regression grades: can they influence rectal cancer therapy decision tree?Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles.Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study.Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0.Controversies and challenges regarding the impact of radiation therapy on survival.Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate?Gene expression profile is associated with chemoradiation resistance in rectal cancer.Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α.Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy.Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer.Can tumor regression grade influence survival outcome in ypT3 rectal cancer?Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancerSerum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer.
P2860
Q26778222-AD12FCF1-B223-46E2-9E9B-DC79EAA416CEQ27008428-B9BFFE6F-7F79-41EE-9EF2-16870EA55222Q27013068-51C165EE-49DA-46AA-BB9B-48F5B1304A84Q30373308-56AC24BA-32ED-46AA-92BB-628AA71B6083Q33890616-614CF18C-04D2-42B7-9C3A-F8D04E1D22B2Q34043383-B4F6ED40-82E9-4391-B830-95203B9AD328Q34169310-BD3C815B-0EDE-44DB-BDA1-AFC532DE792DQ34575250-1F6CAA37-E36E-4992-9ACB-172826221805Q34985904-80E62F81-9BCD-420A-AD6D-AC07A084A265Q34989484-7FE11EEB-1797-4F78-8B5D-84A29CBF2282Q35569457-ACDFB0C9-CBA2-423E-BFEA-E36FF60E09A7Q36102082-317C7DA0-D9C3-4847-AA94-19FC03449635Q36121224-6C0DEFEF-610D-47F4-A019-C358C0B960D2Q36193815-73C4B09A-C76B-4E41-99F8-823B8C676838Q36348179-AF2D23F8-5CFB-497A-954D-8A14181915BAQ36432125-3FA05CDE-49D6-4C76-BD15-8ACFD99227ACQ36516445-95F019B8-95A2-4407-9BFE-E46E02E4924BQ36544809-3C5A1F5F-397E-47FF-8D87-8358B054378EQ36715078-1E4453EA-045B-4A21-9BA0-55FCFB134C73Q36838083-249B422E-5686-4401-B888-38A09689C554Q37016683-C4FBEED2-BCA8-4426-906F-76265AA1F87CQ37239808-8AE7E2C9-5B56-4C12-BE64-9A882E696C8AQ37624171-00B54BD0-AA53-4E95-8FF8-71F97345E435Q37636805-FE1C5758-64CD-4039-8D01-F806820A4864Q37663255-9BE9107E-7835-4CD4-B4BE-B4025B43A6C2Q38035079-E40B06C1-858D-4727-95CB-D4B8A935CF24Q38064749-C6ED8195-12FC-416A-9DE6-CF63589101A3Q38137324-0FAD2045-ABEB-47E4-84CE-9F6CB367747EQ38563947-F9E10D52-48FC-4983-B80E-27FC4F2AB54DQ38623990-15E8FA5F-9C02-47D9-966E-ED9DFA456708Q38736426-4EA80C19-963F-4BF1-B184-72A6B4C5031CQ38884012-46E24F87-545D-4EF7-8E5E-CC203BC7DAFAQ39019287-11492DC3-E0F8-47B8-AF87-61EB486B054FQ39391684-5B4EA5F7-EB3F-4EBD-94A2-497568DCBB5EQ39553689-F2566BF6-1994-45E3-BA50-9A353D2958C9Q41156336-F832E6A8-E66D-4483-8F90-B8D288ACB4A7Q42327700-AFB7108F-B99C-4430-83E2-A953BDAEE1A1Q42380318-A67CF555-24E6-429A-9373-36BB4608E680Q43054579-DEFDC83B-5DE2-44EF-A342-3A43BA1659E9Q44483887-B174E076-6F06-4F04-9B1A-E65EEBAE2DE6
P2860
Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pathologic complete response a ...... ld eradicate local recurrence.
@en
Pathologic complete response a ...... ld eradicate local recurrence.
@nl
type
label
Pathologic complete response a ...... ld eradicate local recurrence.
@en
Pathologic complete response a ...... ld eradicate local recurrence.
@nl
prefLabel
Pathologic complete response a ...... ld eradicate local recurrence.
@en
Pathologic complete response a ...... ld eradicate local recurrence.
@nl
P2093
P2860
P1476
Pathologic complete response a ...... ld eradicate local recurrence.
@en
P2093
Andre da Luz Moreira
Daniel Geisler
David W Dietz
Ian C Lavery
Luca Stocchi
Luiz Felipe de Campos-Lobato
Matthew F Kalady
Victor W Fazio
P2860
P2888
P304
P356
10.1245/S10434-010-1506-1
P577
2011-01-05T00:00:00Z
P6179
1006805502